International Tech Times
SEE OTHER BRANDS

Your science and technology news reporter

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

Press releases published on May 14, 2025

Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements

Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements

SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of …

Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia

Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia

REDWOOD CITY, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that preliminary clinical data from the Phase I COVALENT-103 trial of BMF-500 in …

dLocal Reports 2025 First Quarter Financial Results

dLocal Reports 2025 First Quarter Financial Results

Record highs across key financial and operational metrics. TPV milestone of US$8 billion, +53% YoY and +5% QoQ. In constant currency, TPV increased +72% YoY. Revenue and gross profit record highs of US$217 million and US$85 million. Continued geographic …

Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity

Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity

BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late March 2025 Phase 3 Clinical Trial Results …

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track for sNDA submission in Q3 2025; designed to reduce treatment …

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101

Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext …

Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones

Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease; Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in Q3 2025 Strong Balance Sheet with $294.4 Million in Cash and Cash …

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference

VANCOUVER, British Columbia and BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

On track to report topline results from Phase 2 BESTOW trial in kidney transplantation in fourth quarter of 2025 Tegoprubart used as a key component of immunosuppression regimen in its second transplant of a genetically modified pig kidney into a human …

Wireless Broadband Alliance Services Launches Commercial AFC Service, Enabling Standard Power Wi-Fi in 6 GHz Band Leveraging Critical Spectrum

Wireless Broadband Alliance Services Launches Commercial AFC Service, Enabling Standard Power Wi-Fi in 6 GHz Band Leveraging Critical Spectrum

FCC-certified cloud-based platform drives spectrum innovation for infrastructure providers, network operators and enterprises in high-performance use cases, while protecting incumbent spectrum operations across the U.S. LONDON, UNITED KINGDOM, May 14, …

MDxHealth Reports Q1-2025 Results

MDxHealth Reports Q1-2025 Results

Year-over-year Q1 revenues increase by 22% to $24.3 million 71% year-over-year improvement in adjusted EBITDA in first quarter Conference call with Q…

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.18 Per Share

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.18 Per Share

ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (Nasdaq: HWKN), at its meeting on May 14, 2025, declared a quarterly cash dividend of $0.18 per share, payable June 13, 2025, to shareholders of record at the close …

Vassal Benford & Mally Mall: The Hitmakers Redefining the Sound of a Generation

Vassal Benford & Mally Mall: The Hitmakers Redefining the Sound of a Generation

Beverly Hills, CA, May 14, 2025 (GLOBE NEWSWIRE) -- When you think platinum plaques, Grammy wins, and genre-defying anthems, two names consistently rise to the top: Vassal Benford and Mally Mall. These musical visionaries have long been individually …

Red Cat Reports Financial Results for First Quarter 2025 and Provides Corporate Update

Red Cat Reports Financial Results for First Quarter 2025 and Provides Corporate Update

SAN JUAN, Puerto Rico, May 14, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat" or the "Company"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, reports …

CapitalRevo Reveals Powerful AI-Driven Features Ushering in a New Era of Smart Trading

CapitalRevo Reveals Powerful AI-Driven Features Ushering in a New Era of Smart Trading

CapitalRevo has launched a powerful suite of AI-driven features aimed at transforming the trading experience for users of all levels. The platform now offers real-time market insights, emotion-free decision-making, and adaptive, self-learning algorithms to …

The Little Orange Bubble That Never Sleeps: How NIR’s Free AI Assistant Is Re-Shaping NDIS Support Coordination

The Little Orange Bubble That Never Sleeps: How NIR’s Free AI Assistant Is Re-Shaping NDIS Support Coordination

AI assistant from Navigator In Reach offers free, 24/7 support for NDIS participants seeking faster, clearer coordination help MORPHETT VALE, AUSTRALIA, May 14, 2025 /⁨EINPresswire.com⁩/ -- A free, always-on AI assistant developed by Navigator In Reach ( …

Robex Kiniero-Projekt auf Kurs für erste Goldförderung im vierten Quartal

Robex Kiniero-Projekt auf Kurs für erste Goldförderung im vierten Quartal

WESENTLICHE ASPEKTE: Die Bauarbeiten am Kiniero-Goldprojekt von Robex in Guinea verlaufen weiterhin planmäßig und im Rahmen des Budgets – die erste Goldproduktion ist für das vierte Quartal des Kalenderjahres 2025 vorgesehen. Das Projekt bleibt weiterhin …

Le projet Kiniero de Robex en bonne voie pour une première coulée d’or au quatrième trimestre

Le projet Kiniero de Robex en bonne voie pour une première coulée d’or au quatrième trimestre

FAITS MARQUANTS : La construction du projet aurifère Kiniero de Robex, en Guinée, suit le calendrier et le budget prévus. La première coulée d’or est prévue pour le quatrième trimestre de l’année civile 2025. Aucun accident du travail n’a été signalé à ce …

Boralex announces the election of its directors and highlights of its Annual Meeting of Shareholders

Boralex announces the election of its directors and highlights of its Annual Meeting of Shareholders

MONTREAL, May 14, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) held its annual meeting of shareholders earlier today. During the meeting chaired by Alain Rhéaume, Chairman of the Board, shareholders elected directors and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service